Does NAFLD and related liver fibrosis increase the risk of incident CVD and mortality in patients with hypertension?
NAFLD and liver fibrosis are significant risk factors that may partially mediate the development of cardiovascular disease and mortality in patients with hypertension.
NAFLD and related liver fibrosis are associated with a higher risk of incident CVD and mortality in hypertensives. NAFLD and related liver fibrosis seem to partially mediate hypertension-induced CVD and mortality.
Huang et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: